Results 41 to 50 of about 23,209 (275)

Profiles of Secondary Metabolites (Phenolic Acids, Carotenoids, Anthocyanins, and Galantamine) and Primary Metabolites (Carbohydrates, Amino Acids, and Organic Acids) during Flower Development in Lycoris radiata

open access: yesBiomolecules, 2021
This study aimed to elucidate the variations in primary and secondary metabolites during Lycoris radiata flower development using high performance liquid chromatography (HPLC) and gas chromatography time-of-flight mass spectrometry (GC-TOFMS). The result
C. Park   +7 more
semanticscholar   +1 more source

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial [PDF]

open access: yes, 2017
BACKGROUND/OBJECTIVES: Post-marketing comparative trials describe medication use patterns in diverse, real-world populations. Our objective was to determine if differences in rates of adherence and tolerability exist among new users to ...
Boustani, Malaz A.   +8 more
core   +1 more source

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders

open access: yesMolecules, 2021
The acetylcholinesterase (AChE) inhibitors are the main drugs for symptomatic treatment of neurodegenerative disorders like Alzheimer’s disease. A recently designed, synthesized and tested hybrid compound between the AChE inhibitor galantamine (GAL) and ...
Rumyana Simeonova   +6 more
semanticscholar   +1 more source

Galantamine Effects on Memory, Spatial Cue Utilization, and Neurotrophic Factors in Aged Female Rats

open access: yesCell Transplantation, 2007
Galantamine is an acetylcholine esterase inhibitor that has been approved for use in Alzheimer's disease. However, even though clinical studies indicate efficacy in attenuating some of the symptoms associated with the disease, there are a paucity of ...
K. L. French   +2 more
doaj   +1 more source

Can we predict the response to Galantamine in Alzheimer`s disease patients? [PDF]

open access: yesRomanian Journal of Neurology, 2015
Although considerate progress was obtained by adding imagistic and laboratory test, clinical examination remains the core of the diagnosis for Alzheimer`s disease. After 20 years of experience with anticholinergic drugs we know that only one third of the
Carmen Gavan   +2 more
doaj   +1 more source

Biological activities and chemical composition of methanolic extracts of selected Autochthonous microalgae strains from the Red Sea [PDF]

open access: yes, 2015
Four lipid-rich microalgal species from the Red Sea belonging to three different genera (Nannochloris, Picochlorum and Desmochloris), previously isolated as novel biodiesel feedstocks, were bioprospected for high-value, bioactive molecules.
Carolina Bruno De Sousa   +14 more
core   +4 more sources

Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders

open access: yesComplex Psychiatry, 2021
The kynurenine pathway (KP) is a major route for L-tryptophan (L-TRP) metabolism, yielding a variety of bioactive compounds including kynurenic acid (KYNA), 3-hydroxykynurenine (3-HK), quinolinic acid (QUIN), and picolinic acid (PIC).
M. Y. Bai   +5 more
semanticscholar   +1 more source

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease [PDF]

open access: yes, 2008
Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease (AD) indicate that the short and long term actions of ChEIs are dissimilar. fMRI studies of the ChEI rivastigmine have focused on its short term action.
McGeown, William J   +2 more
core   +2 more sources

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. [PDF]

open access: yes, 2015
This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia.
Abagyan, Ruben   +4 more
core   +3 more sources

Effects of Galantamine and Donepezil on Active and Passive Avoidance Tests in Rats With Induced Hypoxia

open access: yesJournal of Pharmacological Sciences, 2006
.: The cholinergic system undergoes changes with aging and in Alzheimer’s disease. The effects of the anticholinesterase drugs galantamine and donepezil were studied in a model with sodium nitrite-induced hypoxia in rats.
Dimitrova Darinka Slavcheva   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy